21 Aug 2019 --- US-based Elanco Animal Health is to acquire Bayer’s Animal Health business in a US$7.6 billion deal. According to Elanco, the move elevates it as a global animal health company, enhances its portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline. The combination of portfolios and capabilities hopes to “provide a sustained flow of innovation for farmers, veterinarians and pet owners,” says Jeffrey N. Simmons, President and CEO of Elanco.
